TrialCardiovascular drugs and therapy2018

Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension Studies.

Leslie Cho et al.PubMed ↗Publisher ↗

No numbers read from the abstract.